Now showing items 81-83 of 83

    • Cuchacovich Turteltaub, Miguel; Soto, L.; Edwardes, M.; Gutiérrez, M.; Llanos, C.; Pacheco, D.; Sabugo Siraqyan, María Francisca; Alamo, M.; Fuentealba, C.; Villanueva, L.; Gatica, H.; Schiattino, Irene; Salazar, L.; Catalán Martina, Diego; Valenzuela, O.; Salazar Onfray, Flavio; Aguillón Gutiérrez, Juan Carlos (2006)
      Objective: To investigate the influence of -308 tumour necrosis factor-α (TNFα) promoter polymorphism and circulating TNFα levels in the clinical response to adalimumab treatment in patients with rheumatoid arthritis (RA). ...
    • Cuchacovich Turteltaub, Miguel; Ferreira, L.; Aliste, M.; Soto, L.; Cuenca, J.; Cruzat, A.; Gatica, H.; Schiattino, Irene; Pérez, C.; Aguirre A., Luz María; Salazar Onfray, Flavio; Aguillón Gutiérrez, Juan Carlos (2004)
      Objective: To investigate the influence of -308 tumour necrosis factor-α (TNF-α) promoter polymorphism and circulating TNF-α levels in the clinical response to the infliximab treatment in patients with rheumatoid arthritis ...
    • Hetz Flores, Claudio; Glimcher, Laurie H. (2008)
      A unique feature of secretory cells is the proliferation of the endoplasmic reticulum (ER) and Golgi network. The high demand imposed by protein synthesis and folding in secretory cells constitutes an endogenous source of ...